CHKA and hepatocellular carcinoma: We combined direct and indirect evidence from 44 randomized controlled trials comparing 22 different TACE arms in more than three thousand HCC patients undergoing TACE therapy to make several key observations regarding the potential efficacy and safety of CKI.